<DOC>
	<DOCNO>NCT01681706</DOCNO>
	<brief_summary>The purpose non-interventional study implement survey initiative ass HIV prevalence one diseases and/or condition within specific segment population yet diagnose HIV , present care specific disease/condition . The list diseases indicative important indicator disease HIV rather list disease suggest surveillance . This study enrol patient present follow diseases/conditions : 1 . Presenting care malignant lymphoma , irrespective type 2 . Presenting care cervical anal dysplasia cancer , ( Cervical CIN II ) 3 . Presenting care Hepatitis B C virus infection ( acute chronic - irrespective time diagnosis relative time survey ) , 4 . Presenting ongoing mononucleosis-like illness 5 . Presenting unexplained leukocytopenia thrombocytopenia last least 4 week 6 . Presenting seborrheic dermatitis / exanthema 7 . Presenting pneumonia , admit hospital least 24h 8 . Presenting unexplained lymphadenopathy 9 . Presenting peripheral neuropathy unknown cause ( diagnosed neurologist ) 10 . Presenting primary lung cancer 11 . Presenting severe recalcitrant psoriasis ( newly diagnose )</brief_summary>
	<brief_title>HIV Indicator Diseases Across Europe Study</brief_title>
	<detailed_description>Most patient infected HIV across European continent remain undiagnosed ; although percentage varies markedly 15-80 % across continent . Undiagnosed HIV harmful person infected appropriate health intervention delay HIV infection diagnose . It also detrimental society person unaware HIV infection may transmit frequently others person aware HIV status . An important public health issue hence diagnose HIV-infected person earlier course infection . In US , Centers Disease Control Prevention ( CDC ) introduce test guideline person test upon entry hospital system ( `` opt-out '' test guideline ) . At `` HIV Europe '' conference hold November 2007 , general sense approach would suitable Europe . Conversely , conference recommend development focus HIV test patient present certain clinical condition and/or disease ( i.e . indicator condition guide test ) . Cost effectiveness analysis suggest cost saving population HIV prevalence 1 % test although rate may low 0.1 % . However , little - - evidence HIV prevalence various condition disease specific easy identify section society . This true general particularly across European continent . Surveys undertaken investigator : Zangerle , Kitchen , U H Innsbruck , Vassilenko , Minsk Municipal Infectious Diseases Hospital , Necsoi , Clumeck , Saint-Pierre U H Hadziosmanovic , U Sarajevo Begovac , U Hospital Infectious Diseases Pedersen , Mogensen , Abildgaard , Titlestad , Odense U H Dragsted , Roskilde H Sp√§th , U Bonn Sthoeger , Neve-Or AIDS Centre d'Armino Monforte , Mareo , Comi , Centanni , San Paolo H Grzeszczuk , Medical U Bialystok Maltez , H Curry Cabral Castro , HU A Coruna-Hospital Juan Canalejo Masia , HU Elche Estrada , HCU San Carlos Iribarren , H. Donostia Ortega , CH General de Valencia Ocampo , H Xeral-Cies Vernazza , Kantonsspital St. Gallen Perry , Fisher , Elton John Centre , Morris , RIDU Minton , St James 's U H Palfreeman , Leicester Royal Infirmary Gazzard , Sullivan , ChelseaWestminster H Winston , Walsh , St Mary 's H Anderson , Millett , Homerton H NHS Trust Farazmand , Huddersfield Royal Infirmary Ong , Krasnov , Kharkov Regional Clinic Infectious Diseases Kutsyna , State Medical U</detailed_description>
	<criteria>HIV status unknown Presenting care 1 11 indicator disease survey . Known HIV positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Indicator disease</keyword>
</DOC>